Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Current Taxes (2024 - 2025)

Axsome Therapeutics' Current Taxes history spans 2 years, with the latest figure at $101000.0 for Q4 2025.

  • For Q4 2025, Current Taxes fell 89.48% year-over-year to $101000.0; the TTM value through Dec 2025 reached $101000.0, down 89.48%, while the annual FY2025 figure was $101000.0, 89.48% down from the prior year.
  • Current Taxes for Q4 2025 was $101000.0 at Axsome Therapeutics, down from $960000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $960000.0 in Q4 2024 and bottomed at $101000.0 in Q4 2025.